Inventor

MAGNANI JOHN L

US47 patents

⚠️ This page may combine multiple inventors who share the name “MAGNANI JOHN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MAGNANI JOHN L

GLYCOMIMETICS INC

E-selectin antagonist compounds, compositions, and methods of use

Compounds and methods for inhibiting selectin-mediated function

Pan-selectin inhibitor with enhanced pharmacokinetic activity

Compounds and methods for treatment of sickle cell or complications associated therewith

Compounds and methods for treatment of sickle cell disease or complications associated therewith

Specific antagonist for both E- and P-selectins

Heterobifunctional pan-selectin inhibitors

Compounds and methods for inhibiting selectin-mediated function

Heterobifunctional pan-selectin inhibitors

Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas

E-selectin antagonist compounds, compositions, and methods of use

Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells

Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines

Detection and treatment of prostate cancer

E-selectin antagonist compounds, compositions, and methods of use

E-selectin antagonist compounds, compositions, and methods of use

Glycomimetic replacements for hexoses and N-acetyl hexosamines

Highly potent multimeric e-selectin antagonists

Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

E-selectin antagonist compounds, compositions, and methods of use

Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists

Highly potent multimeric e-selectin antagonists

Glycomimetic inhibitors of PA-IL and PA-IIL lectins

E-selectin antagonist compounds, compositions, and methods of use

Methods of mobilizing marrow infiltrating lymphocytes and uses thereof

Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

Heterobifunctional inhibitors of E-selectin and galectin-3

Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin

Detection and treatment of prostate cancer

Heterobifunctional inhibitors of E-selectin and galectin-3

Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4

Galectin-3 inhibiting c-glycosides

MAGNANI JOHN L

Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules

Pan-selectin inhibitor with enhanced pharmacokinetic activity

Heterobifunctional pan-selectin inhibitors

Heterobifunctional pan-selectin inhibitors

Compounds and methods for inhibiting selectin-mediated function

Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas

Treatment of cancers of the blood using selected glycomimetic compounds

UNIV STANFORD

Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules

Methods and compositions for endothelial binding

Leukocyte homing modulation

(unassigned)

Methods of screening for a candidate compound able to bind to CD34+ cells

Methods and compositions for release of CD3430 cells from affinity matrices

GLYCOTECH CORP

Methods for treatment of EGF receptor associated cancers

Pharmaceutical compositions for treatment of EGF receptor associated cancers